Intravenous Ketamine for Suicidal Behavior in Severe Depression with Psychotic Features
Depression is the leading cause of suicide, and antidepressants and modified electroconvulsive therapy (mECT) are the preferred treatment modalities. Ketamine is an established anesthetic agent and evidence for its use in depression is evolving. Here, we discuss the experience of treating severe dep...
Saved in:
Main Authors: | T. V. Pavan Kumar, Divya Bolla, Raj Kiran Donthu, Anzory Pathak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Annals of Indian Psychiatry |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/aip.aip_212_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
by: Moaz Yasser Darwish, et al.
Published: (2025-02-01) -
Examination of Depression Levels in Individuals Aged 65 and Over
by: Rukuye Aylaz, et al.
Published: (2024-12-01) -
RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study
by: Andrea Miranda-Mendizabal, et al.
Published: (2025-02-01) -
Study of Gaming Disorder and Its Association with Depressive Disorder and Anxiety among Medical Students in India
by: Hanee Patel, et al.
Published: (2025-01-01) -
Role of depression in development of functional dyspepsia symptoms
by: D. B. Kolesnikov, et al.
Published: (2011-06-01)